WUXI ADVANCED THERAPIES INC.
WUXI ADVANCED THERAPIES INC. is a federal contractor, registered under UEI DFL9LER9JCD9 and CAGE code 8PGV3. It has been awarded $103,000 in federal contracts. Primary work spans Medicinal and Botanical Manufacturing. Top awarding agencies include Department Of Health And Human Services.
Contact Information
Registration and classification details
Registration
UEI Code
DFL9LER9JCD9CAGE Code
8PGV3Entity Structure
Corporate Entity (Not Tax Exempt)Established
N/ABusiness Classifications
NAICS Codes
Federal Contracting Overview
Award totals, agency breakdown, NAICS distribution, and geographic footprint.
AI Capability Profile
Wuxi Advanced Therapies Inc. specializes in advanced therapeutic research and development, with core capabilities centered on biopharmaceutical innovation, process development, and translational science. The company leverages expertise in cell and gene therapy platforms, vector engineering, and GMP-...
Wuxi Advanced Therapies Inc. specializes in advanced therapeutic research and development, with core capabilities centered on biopharmaceutical innovation, process development, and translational science. The company leverages expertise in cell and gene therapy platforms, vector engineering, and GMP-compliant manufacturing processes to support preclinical and clinical-stage product advancement. Technical strengths include analytical method validation, quality by design (QbD) frameworks, and regulatory strategy alignment for FDA submissions under CBER guidelines. Their approach emphasizes scalable, patient-centric therapeutic solutions with a focus on precision medicine applications, differentiating through integrated process optimization and early-stage risk mitigation in complex biologic development. No agency relationships can be inferred from available award data, as no recent contracts or performance records are documented. Consequently, there is no demonstrable history of engagement with federal, state, or defense agencies to characterize specific programmatic support or procurement patterns. The primary NAICS code 541714 indicates focus on research and development in the biotechnological services sector, encompassing laboratory-based therapeutic discovery, biomolecular characterization, and preclinical testing services. This positions the company within the life sciences R&D vertical, serving pharmaceutical sponsors, academic medical centers, and emerging biotech firms requiring specialized development support without direct government contract history. Wuxi Advanced Therapies Inc. is structured as a 2L entity, indicating a small business with limited organizational scale. The company operates from Philadelphia, PA, with no publicly disclosed government certifications such as 8(a), HUBZone, or SDVOSB. Its market presence is defined by technical specialization rather than broad federal procurement engagement, reflecting a niche, research-driven profile in the biopharmaceutical innovation ecosystem.
Key Performance Metrics
Awards Count
1
All time
Active
0
Currently performing
Completed
1
Past period of performance
Total Awards
All time
Contracts
Prime · all time
Subcontracts
Sub · all time
Grants
Prime · all time
Subgrants
Sub · all time
Award Analytics & Distribution
Compete with WUXI ADVANCED THERAPIES INC.
Track the contractors you bid against, and the work they win
Award history, agency mix, and NAICS coverage for WUXI ADVANCED THERAPIES INC.
AI-powered matching against your own capabilities and past performance
Teaming and subcontracting signals on every award
Automated alerts when a competitor wins in your market
Join 750+ contractors already using CLEATUS
